JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Peristomal Localized Pemphigoid: Is It an Underdiagnosed Condition with a Good Prognosis?

  • 0Can Baykal, MD, is Professor, Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Elizaveta Melnicova Ayas, MD, is Resident; Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Tuğba Atcı, MD, is Assistant Professor; Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Şule Öztürk Sarı, MD, is Associate Professor, Department of Pathology; Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; and Nesimi Büyükbabani, MD, is Professor, Department of Pathology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey and Koç Medical Faculty, Istanbul,; and Rıfkiye Küçükoğlu, MD, is Professor, Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Advances in skin & wound care +

|

May 20, 2025

Abstract

OBJECTIVE

To evaluate the rate of peristomal involvement in a large series of bullous pemphigoid (BP) patients and to focus on the clinical features and the course of the disease of these patients.

METHODS

Bullous pemphigoid patients were investigated retrospectively regarding the rate of peristomal involvement, and the data of these patients, including demographics, diagnosis leading to stoma placement, stoma type and stoma duration, treatment, and follow-up were evaluated in detail. In addition, the authors' results were compared with literature data.

RESULTS

The authors observed peristomal involvement in four cases (1.5%) (male/female: 1) among a cohort of 270 consecutive BP patients. The mean age at BP diagnosis was 69.5 ± 6.8 (63-78) years. Peristomal lesions occurred 4.7 ± 3.8 (1-10) years following stoma placement. Although three patients presented with BP lesions only on peristomal localization (colostomy limited), the fourth patient developed generalized pemphigoid lesions for 6 months followed by only peristomal involvement for 3 years. One patient was lost to follow-up. Topical corticosteroids (n = 3), systemic corticosteroids (n = 2), and dapsone (n = 2) were the treatment of choice in three patients, providing a complete response in a mean follow-up period of 4.7 ± 4 years without any mortality.

CONCLUSIONS

The high rate of peristomal BP patients in this series raised the possibility of misdiagnosis of this specific condition as irritant dermatosis. Peristomal lesions may be isolated as an initial presentation of BP or represent the recurrence. Recognition of peristomal BP showing a favorable prognosis compared with classical BP is important.

Keywords:

Related Concept Videos

Skin Cancer 01:30

3.0K

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies 01:28

75

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

Location of Pain:...

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors 01:24

333

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.

Peptic Ulcer Disease I: Introduction 01:30

114

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...